Yasuhiro Yotsumoto
Career history of Yasuhiro Yotsumoto
Former positions of Yasuhiro Yotsumoto
Companies | Position | Start | End |
---|---|---|---|
Santen GmbH
Santen GmbH Pharmaceuticals: MajorHealth Technology Santen GmbH engages in the development, production, and distribution of pharmaceutical products, with a primary focus on the field of ophthalmology. It offers solutions for the treatment of allergies, age-related macular degeneration, dry eye disease, glaucoma, and infection. The company was founded in 1994 and is headquartered in Munich, Germany. | Chief Executive Officer | 01/03/2012 | - |
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Corporate Officer/Principal | 20/10/2011 | - |
Statistics
International
France | 2 |
Germany | 2 |
Operational
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France. | Health Technology |
Santen GmbH
Santen GmbH Pharmaceuticals: MajorHealth Technology Santen GmbH engages in the development, production, and distribution of pharmaceutical products, with a primary focus on the field of ophthalmology. It offers solutions for the treatment of allergies, age-related macular degeneration, dry eye disease, glaucoma, and infection. The company was founded in 1994 and is headquartered in Munich, Germany. | Health Technology |
- Stock Market
- Insiders
- Yasuhiro Yotsumoto
- Experience